Blue Owl snaps up Sila Realty for $2.4B! Healthcare REIT deal signals strong M&A appetite.
AMTM's flat sales & falling EPS raise caution despite analyst targets. EXLS & CRC show strong growth & margins.
ASTS plunges 9% on satellite orbit failure. Year-to-date losses mount, but annual gains still top 270%.
AVGO's 800% 5-yr gain faces a high 80x P/E. AI demand may justify premium, but AI pullback is a risk.
TREX (26.1x P/E) faces shrinking returns & slow growth. BHE (24.9x P/E) has sales declines & low cash flow.
Importers eye $166B tariff refunds. Tech firms lead potential gains, but cash flow waits 60-90 days.
UPST's 36% revenue growth & 2.6x P/S valuation shine; HTZ & CLOV face cash burn risks.
Sponsored
Must Read